Login / Signup

Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials.

Atsushi HashizumeMasahisa KatsunoKeisuke SuzukiHaruhiko BannoYu TakeuchiMotoshi KawashimaNoriaki SugaTomoo ManoAmane ArakiYasuhiro HijikataAkihiro HirakawaTakashi Tsuboinull null
Published in: Journal of neurology (2019)
The efficacy of leuprorelin acetate for patients with SBMA was statistically similar in two randomized-controlled trials, and suggested that leuprorelin acetate may be effective and safe. Further investigations are needed to clarify the promising efficacy of the drug.
Keyphrases
  • randomized controlled trial
  • spinal cord
  • meta analyses
  • clinical trial
  • spinal cord injury
  • adverse drug